45 results
Page 2 of 3
6-K
EX-4.1
i9t2x725l4we8bqz1l
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
brjiy15d6 sq8qcz
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-4.1
fvxapq callxiv79o
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
na6yr1fr
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-5.2
avgcx szxastsco9
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
eexi v1ko1b0o2h
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
3foulkr2 g24pqvex2e3
23 Jan 20
Annual report (foreign) (amended)
4:31pm
F-3
EX-5.1
0ce6e j00z75t80zxm16
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
EX-5.2
jw131
7 Jun 19
Shelf registration (foreign)
3:31pm
F-3
EX-5.1
rn0iopzng3ge ti2ki
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.1
o1hw tbb4
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
yiruc2
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
exff4nb9si536
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
a5lr1
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
z16omtbk1
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.2
dzktudr9 9v595lft6uu
19 Nov 18
Agreement and Plan of Merger
4:34pm